ID   CAH4_HUMAN              Reviewed;         312 AA.
AC   P22748; B4DQA4; Q6FHI7;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 2.
DT   10-MAY-2017, entry version 183.
DE   RecName: Full=Carbonic anhydrase 4;
DE            EC=4.2.1.1;
DE   AltName: Full=Carbonate dehydratase IV;
DE   AltName: Full=Carbonic anhydrase IV;
DE            Short=CA-IV;
DE   Flags: Precursor;
GN   Name=CA4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1311094; DOI=10.1073/pnas.89.4.1315;
RA   Okuyama T., Sato S., Zhu X.L., Waheed A., Sly W.S.;
RT   "Human carbonic anhydrase IV: cDNA cloning, sequence comparison, and
RT   expression in COS cell membranes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1315-1319(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8325641; DOI=10.1006/geno.1993.1247;
RA   Okuyama T., Batanian J.R., Sly W.S.;
RT   "Genomic organization and localization of gene for human carbonic
RT   anhydrase IV to chromosome 17q.";
RL   Genomics 16:678-684(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 19-35; 113-123 AND 233-239.
RC   TISSUE=Lung;
RX   PubMed=2111324;
RA   Zhu X.L., Sly W.S.;
RT   "Carbonic anhydrase IV from human lung. Purification,
RT   characterization, and comparison with membrane carbonic anhydrase from
RT   human kidney.";
RL   J. Biol. Chem. 265:8795-8801(1990).
RN   [9]
RP   DISULFIDE BONDS.
RX   PubMed=8809084; DOI=10.1006/abbi.1996.0412;
RA   Waheed A., Okuyama T., Heyduk T., Sly W.S.;
RT   "Carbonic anhydrase IV: purification of a secretory form of the
RT   recombinant human enzyme and identification of the positions and
RT   importance of its disulfide bonds.";
RL   Arch. Biochem. Biophys. 333:432-438(1996).
RN   [10]
RP   GPI-ANCHOR AT SER-284, AND MUTAGENESIS OF SER-284.
RX   PubMed=7625839; DOI=10.1016/0003-9861(95)90015-2;
RA   Okuyama T., Waheed A., Kusumoto W., Zhu X.L., Sly W.S.;
RT   "Carbonic anhydrase IV: role of removal of C-terminal domain in
RT   glycosylphosphatidylinositol anchoring and realization of enzyme
RT   activity.";
RL   Arch. Biochem. Biophys. 320:315-322(1995).
RN   [11]
RP   ENZYME REGULATION.
RX   PubMed=16807956; DOI=10.1002/chem.200600159;
RA   Temperini C., Scozzafava A., Vullo D., Supuran C.T.;
RT   "Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA,
RT   VII, and XIV with l- and d-histidine and crystallographic analysis of
RT   their adducts with isoform II: engineering proton-transfer processes
RT   within the active site of an enzyme.";
RL   Chemistry 12:7057-7066(2006).
RN   [12]
RP   ENZYME REGULATION.
RX   PubMed=16686544; DOI=10.1021/jm0603320;
RA   Temperini C., Scozzafava A., Vullo D., Supuran C.T.;
RT   "Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA,
RT   VII, and XIV with L- and D-phenylalanine and crystallographic analysis
RT   of their adducts with isozyme II: stereospecific recognition within
RT   the active site of an enzyme and its consequences for the drug
RT   design.";
RL   J. Med. Chem. 49:3019-3027(2006).
RN   [13]
RP   ENZYME REGULATION.
RX   PubMed=17705204; DOI=10.1002/anie.200701189;
RA   Koehler K., Hillebrecht A., Schulze Wischeler J., Innocenti A.,
RA   Heine A., Supuran C.T., Klebe G.;
RT   "Saccharin inhibits carbonic anhydrases: possible explanation for its
RT   unpleasant metallic aftertaste.";
RL   Angew. Chem. Int. Ed. Engl. 46:7697-7699(2007).
RN   [14]
RP   ENZYME REGULATION.
RX   PubMed=17127057; DOI=10.1016/j.bmcl.2006.11.027;
RA   Temperini C., Innocenti A., Scozzafava A., Mastrolorenzo A.,
RA   Supuran C.T.;
RT   "Carbonic anhydrase activators: L-Adrenaline plugs the active site
RT   entrance of isozyme II, activating better isoforms I, IV, VA, VII, and
RT   XIV.";
RL   Bioorg. Med. Chem. Lett. 17:628-635(2007).
RN   [15]
RP   ENZYME REGULATION.
RX   PubMed=17314045; DOI=10.1016/j.bmcl.2007.01.113;
RA   Temperini C., Innocenti A., Guerri A., Scozzafava A., Rusconi S.,
RA   Supuran C.T.;
RT   "Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-
RT   ray crystal structure of the antiviral drug foscarnet complexed to
RT   human carbonic anhydrase I.";
RL   Bioorg. Med. Chem. Lett. 17:2210-2215(2007).
RN   [16]
RP   ENZYME REGULATION.
RX   PubMed=19186056; DOI=10.1016/j.bmcl.2009.01.038;
RA   Crocetti L., Maresca A., Temperini C., Hall R.A., Scozzafava A.,
RA   Muehlschlegel F.A., Supuran C.T.;
RT   "A thiabendazole sulfonamide shows potent inhibitory activity against
RT   mammalian and nematode alpha-carbonic anhydrases.";
RL   Bioorg. Med. Chem. Lett. 19:1371-1375(2009).
RN   [17]
RP   ENZYME REGULATION.
RX   PubMed=19206230; DOI=10.1021/ja809683v;
RA   Maresca A., Temperini C., Vu H., Pham N.B., Poulsen S.-A.,
RA   Scozzafava A., Quinn R.J., Supuran C.T.;
RT   "Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a
RT   new class of suicide inhibitors.";
RL   J. Am. Chem. Soc. 131:3057-3062(2009).
RN   [18]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME REGULATION.
RX   PubMed=18618712; DOI=10.1002/prot.22144;
RA   Di Fiore A., Monti S.M., Hilvo M., Parkkila S., Romano V., Scaloni A.,
RA   Pedone C., Scozzafava A., Supuran C.T., De Simone G.;
RT   "Crystal structure of human carbonic anhydrase XIII and its complex
RT   with the inhibitor acetazolamide.";
RL   Proteins 74:164-175(2009).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 19-284 IN COMPLEX WITH ZINC
RP   ION.
RX   PubMed=8942978; DOI=10.1073/pnas.93.24.13589;
RA   Stams T., Nair S.K., Okuyama T., Waheed A., Sly W.S.,
RA   Christianson D.W.;
RT   "Crystal structure of the secretory form of membrane-associated human
RT   carbonic anhydrase IV at 2.8-A resolution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:13589-13594(1996).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 19-284 IN COMPLEX WITH
RP   INHIBITORS.
RX   PubMed=20363633; DOI=10.1016/j.bmc.2010.03.014;
RA   Vernier W.F., Chong W., Rewolinski D., Greasley S., Pauly T.A.,
RA   Shaw M., Dinh D.M., Ferre R.A.A., Meador J.W. III, Nukui S.,
RA   Ornelas M., Paz R.L., Reyner E.;
RT   "Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and
RT   IV: structure-based drug design, synthesis, and biological
RT   evaluation.";
RL   Bioorg. Med. Chem. 18:3307-3319(2010).
RN   [21]
RP   INVOLVEMENT IN RP17, VARIANTS RP17 TRP-14 AND SER-219, FUNCTION,
RP   TISSUE SPECIFICITY, AND INTERACTION WITH SLC4A4.
RX   PubMed=15563508; DOI=10.1093/hmg/ddi023;
RA   Yang Z., Alvarez B.V., Chakarova C., Jiang L., Karan G.,
RA   Frederick J.M., Zhao Y., Sauve Y., Li X., Zrenner E., Wissinger B.,
RA   Den Hollander A.I., Katz B., Baehr W., Cremers F.P., Casey J.R.,
RA   Bhattacharya S.S., Zhang K.;
RT   "Mutant carbonic anhydrase 4 impairs pH regulation and causes retinal
RT   photoreceptor degeneration.";
RL   Hum. Mol. Genet. 14:255-265(2005).
RN   [22]
RP   INTERACTION WITH SLC4A4, VARIANT RP17 HIS-69, VARIANT LYS-177, AND
RP   CHARACTERIZATION OF VARIANT RP17 HIS-69.
RX   PubMed=17652713; DOI=10.1167/iovs.06-1515;
RA   Alvarez B.V., Vithana E.N., Yang Z., Koh A.H., Yeung K., Yong V.,
RA   Shandro H.J., Chen Y., Kolatkar P., Palasingam P., Zhang K., Aung T.,
RA   Casey J.R.;
RT   "Identification and characterization of a novel mutation in the
RT   carbonic anhydrase IV gene that causes retinitis pigmentosa.";
RL   Invest. Ophthalmol. Vis. Sci. 48:3459-3468(2007).
RN   [23]
RP   VARIANT RP17 THR-12.
RX   PubMed=20450258; DOI=10.3109/02713680903503512;
RA   Tian Y., Tang L., Cui J., Zhu X.;
RT   "Screening for the carbonic anhydrase IV gene mutations in Chinese
RT   retinitis pigmentosa patients.";
RL   Curr. Eye Res. 35:440-444(2010).
CC   -!- FUNCTION: Reversible hydration of carbon dioxide. May stimulate
CC       the sodium/bicarbonate transporter activity of SLC4A4 that acts in
CC       pH homeostasis. It is essential for acid overload removal from the
CC       retina and retina epithelium, and acid release in the
CC       choriocapillaris in the choroid. {ECO:0000269|PubMed:15563508}.
CC   -!- CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:8942978};
CC   -!- ENZYME REGULATION: Activated by histamine, L-adrenaline, D-
CC       phenylalanine, L- and D-histidine. Inhibited by coumarins,
CC       saccharin, sulfonamide derivatives such as acetazolamide and
CC       Foscarnet (phosphonoformate trisodium salt).
CC       {ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16807956,
CC       ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045,
CC       ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:18618712,
CC       ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=21.5 mM for CO(2) {ECO:0000269|PubMed:18618712};
CC   -!- SUBUNIT: Interacts with SLC4A4. {ECO:0000269|PubMed:15563508,
CC       ECO:0000269|PubMed:17652713, ECO:0000269|PubMed:20363633,
CC       ECO:0000269|PubMed:8942978}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P22748-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P22748-2; Sequence=VSP_055973, VSP_055974;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in the endothelium of the
CC       choriocapillaris in eyes (at protein level). Not expressed in the
CC       retinal epithelium at detectable levels.
CC       {ECO:0000269|PubMed:15563508}.
CC   -!- DISEASE: Retinitis pigmentosa 17 (RP17) [MIM:600852]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:15563508,
CC       ECO:0000269|PubMed:17652713, ECO:0000269|PubMed:20450258}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry. Defective acid overload removal from
CC       retina and retinal epithelium, due to mutant CA4, is responsible
CC       for photoreceptor degeneration, indicating that impaired pH
CC       homeostasis is the most likely cause underlying the RP17
CC       phenotype.
CC   -!- SIMILARITY: Belongs to the alpha-carbonic anhydrase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M83670; AAA35630.1; -; mRNA.
DR   EMBL; L10955; AAA35625.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; L10951; AAA35625.1; JOINED; Genomic_DNA.
DR   EMBL; L10953; AAA35625.1; JOINED; Genomic_DNA.
DR   EMBL; L10954; AAA35625.1; JOINED; Genomic_DNA.
DR   EMBL; L10955; AAA35626.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; L10954; AAA35626.1; JOINED; Genomic_DNA.
DR   EMBL; AK289715; BAF82404.1; -; mRNA.
DR   EMBL; AK298710; BAG60866.1; -; mRNA.
DR   EMBL; CR541766; CAG46565.1; -; mRNA.
DR   EMBL; AC025048; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94362.1; -; Genomic_DNA.
DR   EMBL; BC057792; AAH57792.1; -; mRNA.
DR   EMBL; BC069649; AAH69649.1; -; mRNA.
DR   EMBL; BC074768; AAH74768.1; -; mRNA.
DR   CCDS; CCDS11624.1; -. [P22748-1]
DR   PIR; A45745; CRHU4.
DR   RefSeq; NP_000708.1; NM_000717.4. [P22748-1]
DR   RefSeq; XP_016880501.1; XM_017025012.1.
DR   UniGene; Hs.89485; -.
DR   PDB; 1ZNC; X-ray; 2.80 A; A/B=19-284.
DR   PDB; 3F7B; X-ray; 2.05 A; A/B=19-284.
DR   PDB; 3F7U; X-ray; 2.00 A; A/B/C/D=19-284.
DR   PDB; 3FW3; X-ray; 1.72 A; A/B=19-284.
DR   PDB; 5IPZ; X-ray; 2.10 A; A/B/C/D=19-284.
DR   PDBsum; 1ZNC; -.
DR   PDBsum; 3F7B; -.
DR   PDBsum; 3F7U; -.
DR   PDBsum; 3FW3; -.
DR   PDBsum; 5IPZ; -.
DR   ProteinModelPortal; P22748; -.
DR   SMR; P22748; -.
DR   BioGrid; 107217; 6.
DR   IntAct; P22748; 4.
DR   STRING; 9606.ENSP00000300900; -.
DR   BindingDB; P22748; -.
DR   ChEMBL; CHEMBL3729; -.
DR   DrugBank; DB00819; Acetazolamide.
DR   DrugBank; DB00436; Bendroflumethiazide.
DR   DrugBank; DB00562; Benzthiazide.
DR   DrugBank; DB01194; Brinzolamide.
DR   DrugBank; DB00880; Chlorothiazide.
DR   DrugBank; DB00606; Cyclothiazide.
DR   DrugBank; DB01144; Diclofenamide.
DR   DrugBank; DB00869; Dorzolamide.
DR   DrugBank; DB08846; Ellagic Acid.
DR   DrugBank; DB00311; Ethoxzolamide.
DR   DrugBank; DB00999; Hydrochlorothiazide.
DR   DrugBank; DB00774; Hydroflumethiazide.
DR   DrugBank; DB00703; Methazolamide.
DR   DrugBank; DB00232; Methyclothiazide.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB01021; Trichlormethiazide.
DR   DrugBank; DB00909; Zonisamide.
DR   GuidetoPHARMACOLOGY; 2599; -.
DR   iPTMnet; P22748; -.
DR   PhosphoSitePlus; P22748; -.
DR   BioMuta; CA4; -.
DR   DMDM; 115465; -.
DR   EPD; P22748; -.
DR   PaxDb; P22748; -.
DR   PeptideAtlas; P22748; -.
DR   PRIDE; P22748; -.
DR   DNASU; 762; -.
DR   Ensembl; ENST00000300900; ENSP00000300900; ENSG00000167434. [P22748-1]
DR   Ensembl; ENST00000586876; ENSP00000467465; ENSG00000167434. [P22748-2]
DR   GeneID; 762; -.
DR   KEGG; hsa:762; -.
DR   UCSC; uc002iym.5; human. [P22748-1]
DR   CTD; 762; -.
DR   DisGeNET; 762; -.
DR   GeneCards; CA4; -.
DR   GeneReviews; CA4; -.
DR   HGNC; HGNC:1375; CA4.
DR   HPA; HPA011089; -.
DR   HPA; HPA017258; -.
DR   MalaCards; CA4; -.
DR   MIM; 114760; gene.
DR   MIM; 600852; phenotype.
DR   neXtProt; NX_P22748; -.
DR   OpenTargets; ENSG00000167434; -.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA25991; -.
DR   eggNOG; KOG0382; Eukaryota.
DR   eggNOG; COG3338; LUCA.
DR   GeneTree; ENSGT00760000118915; -.
DR   HOGENOM; HOG000112637; -.
DR   HOVERGEN; HBG002837; -.
DR   InParanoid; P22748; -.
DR   KO; K18246; -.
DR   OMA; KQTWTVQ; -.
DR   OrthoDB; EOG091G0XFM; -.
DR   PhylomeDB; P22748; -.
DR   TreeFam; TF316425; -.
DR   BRENDA; 4.2.1.1; 2681.
DR   Reactome; R-HSA-1237044; Erythrocytes take up carbon dioxide and release oxygen.
DR   Reactome; R-HSA-1247673; Erythrocytes take up oxygen and release carbon dioxide.
DR   Reactome; R-HSA-1475029; Reversible hydration of carbon dioxide.
DR   SABIO-RK; P22748; -.
DR   EvolutionaryTrace; P22748; -.
DR   GeneWiki; Carbonic_anhydrase_4; -.
DR   GenomeRNAi; 762; -.
DR   PRO; PR:P22748; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000167434; -.
DR   CleanEx; HS_CA4; -.
DR   ExpressionAtlas; P22748; baseline and differential.
DR   Genevisible; P22748; HS.
DR   GO; GO:0031362; C:anchored component of external side of plasma membrane; IDA:DFLAT.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:DFLAT.
DR   GO; GO:0031526; C:brush border membrane; IDA:DFLAT.
DR   GO; GO:0009986; C:cell surface; IDA:DFLAT.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IDA:DFLAT.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:DFLAT.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:DFLAT.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IDA:DFLAT.
DR   GO; GO:0030667; C:secretory granule membrane; IDA:DFLAT.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:DFLAT.
DR   GO; GO:0030658; C:transport vesicle membrane; IDA:DFLAT.
DR   GO; GO:0004089; F:carbonate dehydratase activity; TAS:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0015701; P:bicarbonate transport; IMP:DFLAT.
DR   GO; GO:0006730; P:one-carbon metabolic process; IEA:InterPro.
DR   Gene3D; 3.10.200.10; -; 1.
DR   InterPro; IPR001148; Carbonic_anhydrase_a.
DR   InterPro; IPR023561; Carbonic_anhydrase_a-class.
DR   InterPro; IPR018338; Carbonic_anhydrase_a-class_CS.
DR   InterPro; IPR018343; Carbonic_anhydrase_CA4.
DR   PANTHER; PTHR18952; PTHR18952; 1.
DR   PANTHER; PTHR18952:SF153; PTHR18952:SF153; 1.
DR   Pfam; PF00194; Carb_anhydrase; 1.
DR   SMART; SM01057; Carb_anhydrase; 1.
DR   SUPFAM; SSF51069; SSF51069; 1.
DR   PROSITE; PS00162; ALPHA_CA_1; 1.
DR   PROSITE; PS51144; ALPHA_CA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; GPI-anchor; Lipoprotein; Lyase; Membrane; Metal-binding;
KW   Polymorphism; Reference proteome; Retinitis pigmentosa; Signal; Zinc.
FT   SIGNAL        1     18       {ECO:0000269|PubMed:2111324}.
FT   CHAIN        19    284       Carbonic anhydrase 4.
FT                                /FTId=PRO_0000004226.
FT   PROPEP      285    312       Removed in mature form.
FT                                /FTId=PRO_0000004227.
FT   DOMAIN       21    285       Alpha-carbonic anhydrase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01134}.
FT   REGION      225    226       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00918}.
FT   ACT_SITE     88     88       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:P00918}.
FT   METAL       115    115       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:8942978}.
FT   METAL       117    117       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:8942978}.
FT   METAL       140    140       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:8942978}.
FT   LIPID       284    284       GPI-anchor amidated serine.
FT                                {ECO:0000269|PubMed:7625839}.
FT   DISULFID     24     36       {ECO:0000269|PubMed:8809084}.
FT   DISULFID     46    229       {ECO:0000269|PubMed:8809084}.
FT   VAR_SEQ      90    106       VMMLLENKASISGGGLP -> GWNPGERGLPATGGGTV
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055973.
FT   VAR_SEQ     107    312       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055974.
FT   VARIANT      12     12       A -> T (in RP17).
FT                                {ECO:0000269|PubMed:20450258}.
FT                                /FTId=VAR_071430.
FT   VARIANT      14     14       R -> W (in RP17; abolishes interaction
FT                                with SLC4A4; impaired SLC4A4
FT                                cotransporter activity stimulation;
FT                                dbSNP:rs104894559).
FT                                {ECO:0000269|PubMed:15563508}.
FT                                /FTId=VAR_024749.
FT   VARIANT      69     69       R -> H (in RP17; has no effect on
FT                                catalytic activity; loss of interaction
FT                                with SLC4A4; dbSNP:rs121434552).
FT                                {ECO:0000269|PubMed:17652713}.
FT                                /FTId=VAR_071431.
FT   VARIANT     177    177       N -> K (in dbSNP:rs185942554).
FT                                {ECO:0000269|PubMed:17652713}.
FT                                /FTId=VAR_071432.
FT   VARIANT     219    219       R -> S (in RP17; no catalytic activity;
FT                                impaired SLC4A4 cotransporter activity
FT                                stimulation; dbSNP:rs121434551).
FT                                {ECO:0000269|PubMed:15563508}.
FT                                /FTId=VAR_024750.
FT   VARIANT     237    237       V -> L (in dbSNP:rs2229178).
FT                                /FTId=VAR_048680.
FT   MUTAGEN     284    284       S->F: Loss of C-terminal domain removal
FT                                and inactivation.
FT                                {ECO:0000269|PubMed:7625839}.
FT   CONFLICT     24     24       C -> E (in Ref. 8; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX        26     29       {ECO:0000244|PDB:3FW3}.
FT   HELIX        39     41       {ECO:0000244|PDB:3FW3}.
FT   TURN         44     47       {ECO:0000244|PDB:3FW3}.
FT   STRAND       48     50       {ECO:0000244|PDB:3FW3}.
FT   HELIX        58     60       {ECO:0000244|PDB:3FW3}.
FT   STRAND       61     63       {ECO:0000244|PDB:3FW3}.
FT   STRAND       70     77       {ECO:0000244|PDB:3FW3}.
FT   STRAND       82     85       {ECO:0000244|PDB:3FW3}.
FT   STRAND       87     93       {ECO:0000244|PDB:3FW3}.
FT   STRAND       99    102       {ECO:0000244|PDB:3FW3}.
FT   STRAND      109    118       {ECO:0000244|PDB:3FW3}.
FT   STRAND      127    130       {ECO:0000244|PDB:3FW3}.
FT   STRAND      136    145       {ECO:0000244|PDB:3FW3}.
FT   STRAND      162    175       {ECO:0000244|PDB:3FW3}.
FT   HELIX       178    180       {ECO:0000244|PDB:3FW3}.
FT   HELIX       181    186       {ECO:0000244|PDB:3FW3}.
FT   HELIX       187    189       {ECO:0000244|PDB:3FW3}.
FT   STRAND      196    198       {ECO:0000244|PDB:3FW3}.
FT   HELIX       205    207       {ECO:0000244|PDB:3FW3}.
FT   HELIX       211    214       {ECO:0000244|PDB:3FW3}.
FT   STRAND      217    222       {ECO:0000244|PDB:3FW3}.
FT   STRAND      233    240       {ECO:0000244|PDB:3FW3}.
FT   STRAND      242    245       {ECO:0000244|PDB:3FW3}.
FT   HELIX       246    255       {ECO:0000244|PDB:3FW3}.
FT   STRAND      257    259       {ECO:0000244|PDB:3FW3}.
FT   STRAND      264    266       {ECO:0000244|PDB:3F7U}.
SQ   SEQUENCE   312 AA;  35032 MW;  EF5F182474ABE9B0 CRC64;
     MRMLLALLAL SAARPSASAE SHWCYEVQAE SSNYPCLVPV KWGGNCQKDR QSPINIVTTK
     AKVDKKLGRF FFSGYDKKQT WTVQNNGHSV MMLLENKASI SGGGLPAPYQ AKQLHLHWSD
     LPYKGSEHSL DGEHFAMEMH IVHEKEKGTS RNVKEAQDPE DEIAVLAFLV EAGTQVNEGF
     QPLVEALSNI PKPEMSTTMA ESSLLDLLPK EEKLRHYFRY LGSLTTPTCD EKVVWTVFRE
     PIQLHREQIL AFSQKLYYDK EQTVSMKDNV RPLQQLGQRT VIKSGAPGRP LPWALPALLG
     PMLACLLAGF LR
//
